Is the routine use of intravenous immunoglobulin treatment in neurologic disorders justified? No.
Karussis
D
D
Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. karus@cc.huji.ac.il
Abramsky
O
O
D002493:Central Nervous System Diseases / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D010507:Periodicity; D018570:Risk Assessment
D016756:Immunoglobulins, Intravenous